A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA-BN (IMVAMUNE) Smallpox Vaccine in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
- West, Dennis P (Co-Investigator)
- Laumann, Anne E (PD/PI)
Project: Research project